This is a StreetInsider.com Premium Only Page

SAGE Therapeutics (SAGE) – StreetInsider.com Reports

Dec 11, 2023 04:09 PM Deutsche Bank Starts Sage Therapeutics (SAGE) at Hold

Nov 8, 2023 06:56 AM Sage Therapeutics (SAGE) PT Lowered to $21 at RBC Capital

Nov 8, 2023 06:54 AM Sage Therapeutics (SAGE) PT Lowered to $24 at Scotiabank

Nov 7, 2023 07:42 AM SAGE Therapeutics (SAGE) Enters Sales Agreement with Cowen for Up to $250M Shares

Nov 7, 2023 06:34 AM SAGE Therapeutics (SAGE) Misses Q3 EPS by 69c

Oct 18, 2023 06:30 AM SAGE Therapeutics (SAGE) Granted FDA Orphan Drug Designation for SAGE-718

Oct 16, 2023 06:00 AM Sage Therapeutics (SAGE) PT Raised to $25 at Goldman Sachs

Oct 13, 2023 06:02 AM Sage Therapeutics (SAGE) PT Raised to $25 at Goldman Sachs

Sep 8, 2023 07:52 AM Sage Therapeutics (SAGE) PT Lowered to $24 at BofA Securities

Sep 7, 2023 06:39 AM Sage Therapeutics (SAGE) PT Raised to $20 at Mizuho Securities

Sep 7, 2023 06:12 AM Sage Therapeutics (SAGE) PT Lowered to $22 at RBC Capital

Sep 1, 2023 08:13 AM Sage Therapeutics (SAGE) PT Lowered to $24 at TD Cowen

Sep 1, 2023 06:51 AM Sage Therapeutics (SAGE) PT Raised to $27 at Scotiabank

Aug 31, 2023 08:11 AM Salesforce, Crowdstrike, Ciena rise premarket; Dollar General slumps

Aug 31, 2023 06:30 AM SAGE Therapeutics (SAGE) Implements Strategic Reorganization to Support Plans for ZURZUVAE Commercial Launch

Aug 9, 2023 08:19 AM Sage Therapeutics (SAGE) PT Lowered to $20 at Morgan Stanley

Aug 8, 2023 09:16 AM Sage Therapeutics (SAGE) PT Lowered to $28 at TD Cowen

Aug 8, 2023 07:41 AM Goldman Sachs Downgrades Sage Therapeutics (SAGE) to Neutral, 'stepping to the sidelines as we await more clarity'

Aug 8, 2023 06:54 AM Needham & Company Downgrades Sage Therapeutics (SAGE) to Hold

Aug 8, 2023 06:42 AM Sage Therapeutics (SAGE) PT Lowered to $19 at Mizuho Securities

Aug 8, 2023 06:41 AM Sage Therapeutics (SAGE) PT Lowered to $27 at H.C. Wainwright

Aug 8, 2023 05:30 AM Canaccord Genuity Downgrades Sage Therapeutics (SAGE) to Hold

Aug 8, 2023 04:39 AM Sage Therapeutics (SAGE) PT Lowered to $20 at Truist Securities

Aug 7, 2023 04:56 PM Oppenheimer Reiterates Perform Rating on Sage Therapeutics (SAGE)

Aug 7, 2023 12:56 PM BofA Securities Downgrades Sage Therapeutics (SAGE) to Neutral

Aug 7, 2023 12:44 PM Sage tumbles to record low on clinical depression pill setback

Aug 7, 2023 10:12 AM Stifel Downgrades Sage Therapeutics (SAGE) to Hold, 'we think Biogen is unlikely to buy Sage outright '

Aug 7, 2023 07:23 AM Wedbush Downgrades Sage Therapeutics (SAGE) to Neutral

Aug 7, 2023 07:12 AM SAGE Therapeutics (SAGE) sinks nearly 50% as trading resumes following CRL

Aug 7, 2023 07:04 AM Sage, Biogen receive setback despite FDA approval of postpartum depression drug. This is why

Aug 7, 2023 06:47 AM SAGE Therapeutics (SAGE) to resume trading at 7:10AM ET

Aug 7, 2023 06:44 AM SAGE Therapeutics (SAGE) Misses Q2 EPS by 13c

Aug 7, 2023 06:24 AM SAGE Therapeutics (SAGE), Biogen (BIIB) ZURZUVAETM approved in PPD, receives CRL for MDD

Aug 7, 2023 03:10 AM RBC Capital Downgrades Sage Therapeutics (SAGE) to Sector Perform

Aug 7, 2023 02:22 AM Oppenheimer Downgrades Sage Therapeutics (SAGE) to Perform

Aug 1, 2023 04:42 AM Increasing unusual call option volume: TUO KVUE ETRN YELL NEGG INVZ SAGE

Jul 27, 2023 05:04 AM Scotiabank Starts Sage Therapeutics (SAGE) at Sector Outperform

May 9, 2023 08:00 AM Sage Therapeutics (SAGE) PT Lowered to $49 at Morgan Stanley

May 3, 2023 09:28 AM Sage Therapeutics (SAGE) PT Raised to $56 at BofA Securities

May 3, 2023 08:09 AM Sage Therapeutics (SAGE) PT Lowered to $70 at Oppenheimer

May 2, 2023 04:08 PM Sage Therapeutics (SAGE) PT Raised to $63 at RBC Capital

May 2, 2023 06:36 AM SAGE Therapeutics (SAGE) Reports Q1, Provides Pipeline and Business Progress

May 2, 2023 06:34 AM SAGE Therapeutics (SAGE) Tops Q1 EPS by 4c

Mar 13, 2023 06:14 AM RBC Capital Upgrades Sage Therapeutics (SAGE) to Outperform

Feb 28, 2023 07:07 AM Sage Therapeutics (SAGE) PT Raised to $61 at JPMorgan

Feb 22, 2023 06:31 AM SAGE Therapeutics (SAGE) Granted Orphan Drug Designation for SAGE-718 in EU

Feb 22, 2023 06:31 AM SAGE Therapeutics (SAGE) Granted Orphan Drug Designation for SAGE-718 in EU

Feb 17, 2023 07:06 AM Sage Therapeutics (SAGE) PT Raised to $42 at BMO Capital

Feb 17, 2023 06:55 AM Sage Therapeutics (SAGE) PT Raised to $45 at Mizuho Securities

Feb 16, 2023 01:38 PM Sage Therapeutics (SAGE) PT Raised to $46 at Citi